A second locally manufactured COVID-19 vaccine will soon begin human trials in Iran, officials announced. The vaccine, called Razi COV-Pars, was unveiled in a ceremony in Tehran attended by a host of high-level officials. It has been made by the Razi Vaccine and Serum Research Institute, Iran’s oldest vaccine institute with a history of almost 100 years. According to the spokesman of Iran’s Food and Drug Administration, Kianoush Jahanpour, the vaccine will be tested on 130 volunteers in its first phase. He said Razi COV-Pars is an mRNA vaccine that reconstructs a harmless...